CAR-T Trial for Triple-Negative Breast Cancer Under Way
Researchers reported early findings of a trial evaluating chimeric antigen receptor T-cell therapy for a subset of triple-negative breast cancer patients.
Researchers reported early findings of a trial evaluating chimeric antigen receptor T-cell therapy for a subset of triple-negative breast cancer patients.
The San Antonio Breast Cancer Symposium will take place from December 4-8 at the Henry B. Gonzalez Convention Center in Texas.